Mystery caller study on emergency contraception in Germany!

By João L. Carapinha

June 20, 2023

Researchers examined immediate availability, pricing, and counseling aspects of oral emergency contraception in Berlin pharmacies.
Results included:

✅ Ulipristal acetate prices ranged from €15.95 to €42.95 (median €35.00)
✅ Levonorgestrel prices ranged from €10.60 to €32.49 (median €22.00)

Great access, but high price ranges pose challenges. A comparison app could help minimize costs. Pharmacy staff training is essential for providing “adequate” counseling.

Reference url

Recent Posts

diabetes care South Africa
     

A Shared-Value Model for Enhancing Diabetes Care in South Africa

🌍 How can innovative models transform diabetes care in South Africa?

Discover how Discovery Health’s shared-value program is not only improving patient outcomes through enhanced glycemic control, but also reducing healthcare costs. This strategic approach is making significant strides in diabetes management, setting a precedent for future healthcare innovations.

Curious to learn more? Dive into the full article for an in-depth look at the program’s impact!

#SyenzaNews #HealthcareInnovation #HealthEconomics #DigitalTransformation

oral cancer East Africa
   

Oral Cancer in East Africa: The Need for Early Detection

💡 Did you know that Toombak use is a leading risk factor for oral cancer in East Africa?

A recent scoping review sheds light on the shocking prevalence of oral cancer in the region, emphasising the urgent need for public health interventions and improved early detection strategies. Enhancing awareness around risk factors like Toombak, tobacco, and alcohol for tackling this growing health crisis.

Curious about the key insights and their implications for health economics? Look into the full article to find out more!

#SyenzaNews #HealthEconomics #Oncology #GlobalHealth

Novartis patent cliff layoffs
     

Engineering Resilience: Mastering Pharma Patent Expiration Strategy

🚨 Are you still reacting to pharmaceutical patent expirations with layoffs and litigation, or are you ready to engineer a strategy that turns the patent cliff into your next competitive edge?

Patent expirations don’t have to derail your pharma portfolio. Learn how to outmaneuver generics and transform challenges into advantages. Dive into our latest insights and take control today.

#SyenzaNews #pharmaceuticals #innovation #PharmaStrategy #patentcliffs

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.